Minimally invasive biomarker confirms glial activation present in Alzheimer's disease: a preliminary study
Napapon Sailasuta, Kent Harris, Thao Tran, Brian RossClinical MR Unit, Huntington Medical Research Institutes, Pasadena, CA, USAAbstract: We applied 13C magnetic resonance spectroscopy (MRS), a nonradioactive, noninvasive brain imaging technique, to quantify the oxidation of [1-13C] acetate in a con...
Guardado en:
Autores principales: | Tran T, Harris K, Sailasuta N, Ross B |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5ba6dcdf4ac942c3afd7e47b352ab4ae |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer's disease in the Netherlands
por: Hoogveldt B, et al.
Publicado: (2011) -
Alzheimer's disease and blood-based biomarkers – potential contexts of use
por: Zvěřová M
Publicado: (2018) -
Editor's choice
por: Pinder RM
Publicado: (2012) -
Present and prospective clinical therapeutic regimens for Alzheimer’s disease
por: Mustafa M Husain, et al.
Publicado: (2008) -
Galantamine treatment in Alzheimer's disease: response and long-term outcome in a routine clinical setting
por: Wallin ÅK, et al.
Publicado: (2011)